99 related articles for article (PubMed ID: 183037)
1. Studies on a test vaccine for equine influenza virus. II. Field trials.
Nagamine T; Asahara T; Ide S; Yoshimura M; Igarashi Y
Kitasato Arch Exp Med; 1975 Sep; 48(2-3):69-82. PubMed ID: 183037
[No Abstract] [Full Text] [Related]
2. Studies on a test vaccine for equine influenza virus. I. Production of a test vaccine.
Nagamine T; Asahara T; Higashihara M; Igarashi Y
Kitasato Arch Exp Med; 1975 Sep; 48(2-3):53-67. PubMed ID: 183036
[No Abstract] [Full Text] [Related]
3. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
Morley PS; Townsend HG; Bogdan JR; Haines DM
J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
[TBL] [Abstract][Full Text] [Related]
6. Authors do not believe article provides evidence of vaccine efficacy.
Morley PS; Townsend HG; Haines DM
Am J Vet Res; 2001 May; 62(5):648. PubMed ID: 11341378
[No Abstract] [Full Text] [Related]
7. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
Breathnach CC; Rudersdorf R; Lunn DP
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
[TBL] [Abstract][Full Text] [Related]
8. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
[TBL] [Abstract][Full Text] [Related]
9. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
Bogdan JR; Morley PS; Townsend HG; Haines DM
Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
[TBL] [Abstract][Full Text] [Related]
10. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against equine influenza: quid novi?
Paillot R; Hannant D; Kydd JH; Daly JM
Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
[TBL] [Abstract][Full Text] [Related]
12. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
[TBL] [Abstract][Full Text] [Related]
13. [Route of inoculation and aluminium hydroxide influences in the immunological response of horses vaccinated against equine influenza (author's transl)].
Cunha RG; da Silva Passos W; Rodrigues AF
Arq Inst Biol (Sao Paulo); 1973; 40(4):357-68. PubMed ID: 4377407
[No Abstract] [Full Text] [Related]
14. A serologic study of equine influenza.
Halterman LG; McQueen JL
J Am Vet Med Assoc; 1968 Oct; 153(8):1069-73. PubMed ID: 5693156
[No Abstract] [Full Text] [Related]
15. Questions validity of equine vaccine field studies.
Piontkowski MD
J Am Vet Med Assoc; 1999 Sep; 215(5):620-1. PubMed ID: 10476701
[No Abstract] [Full Text] [Related]
16. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
17. [Contribution to the antigenic study of influenza viruses in animals. II.--Antibodies, antineuraminidase in horse: conditions of apparition and importance (author's transl)].
Fontaine M; Fontaine M
Ann Rech Vet; 1975; 6(4):411-20. PubMed ID: 1231622
[TBL] [Abstract][Full Text] [Related]
18. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus.
McCollum WH
Am J Vet Res; 1986 Sep; 47(9):1931-4. PubMed ID: 3021027
[TBL] [Abstract][Full Text] [Related]
19. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
20. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
